Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Ascendis Pharma
Ascendis Pharma
(ASND)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Skytrofa
Lonapegsomatropin
2021-08-25
Growth and development
Skytrofa (previously lonapegsomatropin ascendis pharma)
Lonapegsomatropin
2022-01-11
Growth and development
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lonapegsomatropin
healthy volunteers/patients
,
laron syndrome
,
pituitary dwarfism
,
endocrine system diseases
,
failure to thrive
,
turner syndrome
,
pituitary diseases
,
sex chromosome disorders
,
chromosome disorders
,
noonan syndrome
,
dwarfism
,
sex chromosome disorders of sex development
Palopegteriparatide
hypoparathyroidism
,
endocrine system diseases
,
parathyroid diseases
Gilvetmab
urinary bladder neoplasms
,
glandular and epithelial neoplasms
,
myoepithelioma
,
hepatitis c
,
hepatitis
,
hepatitis a
,
multiple myeloma
,
neoplasms by histologic type
,
urinary bladder diseases
,
astrocytoma
,
myeloid leukemia acute
,
gata2 deficiency
,
pancreatic neoplasms
,
colorectal neoplasms
,
glioblastoma
,
colonic neoplasms
,
cutaneous malignant melanoma
,
prostatic neoplasms
,
glioma
,
transitional cell carcinoma
,
liver neoplasms
,
small cell lung carcinoma
,
pancreatic ductal carcinoma
,
adenocarcinoma
,
urologic neoplasms
,
stomach neoplasms
,
endometrial neoplasms
,
carcinoma
,
squamous cell carcinoma
,
recurrence
,
neoplasms by site
,
rectal neoplasms
,
ovarian neoplasms
,
chordoma
,
biliary tract neoplasms
,
hepatocellular carcinoma
,
sarcoma
,
microsatellite instability
,
gliosarcoma
,
non-hodgkin lymphoma
,
hodgkin disease
,
uterine cervical neoplasms
,
follicular lymphoma
,
lymphoma
,
squamous cell neoplasms
,
female genital neoplasms
,
endometrioid carcinoma
,
spinocerebellar degenerations
,
neuroendocrine tumors
,
gastrointestinal neoplasms
,
adenocarcinoma of lung
,
basal cell carcinoma
,
basal cell neoplasms
,
nose neoplasms
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
t-cell lymphoma peripheral
,
oropharyngeal neoplasms
,
prostatic diseases
,
cholangiocarcinoma
,
diffuse intrinsic pontine glioma
,
hematologic neoplasms
,
b-cell chronic lymphocytic leukemia
,
bile duct neoplasms
,
genetic therapy
,
smoldering multiple myeloma
,
carcinosarcoma
,
urogenital neoplasms
,
small cell carcinoma
,
penile neoplasms
,
adrenocortical carcinoma
,
mesothelioma
,
drug-related side effects and adverse reactions
,
lung diseases
,
precancerous conditions
,
bronchopulmonary dysplasia
,
tobacco smoking
,
b-cell lymphoma marginal zone
,
mantle-cell lymphoma
,
waldenstrom macroglobulinemia
,
large b-cell lymphoma diffuse
,
burkitt lymphoma
,
oligodendroglioma
,
merkel cell carcinoma
,
hereditary nonpolyposis colorectal neoplasms
,
b-cell lymphoma
,
disease
,
melanoma
,
non-small-cell lung carcinoma
,
neoplasms
,
neoplasm metastasis
,
squamous cell carcinoma of head and neck
,
renal cell carcinoma
,
lung neoplasms
,
breast neoplasms
,
head and neck neoplasms
,
brain neoplasms
,
kidney neoplasms
,
triple negative breast neoplasms
,
skin neoplasms
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
pathologic complete response
Aspartame
healthy volunteers/patients
,
laron syndrome
,
pituitary dwarfism
,
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
megakaryoblastic leukemia acute
,
monocytic leukemia acute
,
myelomonocytic leukemia acute
,
myeloid leukemia
,
erythroblastic leukemia acute
,
neoplasms
,
dyspnea
,
asthma
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
inflammation
Bevifimod
hereditary nephritis
Nadide
pharmacokinetics
,
peripheral nervous system diseases
,
diabetic neuropathies
,
neuralgia
,
postherpetic neuralgia
,
pain
,
polyneuropathies
Endocrine
renal cell carcinoma
,
carcinoma
,
non-small-cell lung carcinoma
,
endometrial neoplasms
,
hepatocellular carcinoma
,
stomach neoplasms
,
melanoma
,
liver neoplasms
,
mesothelioma
,
gastrointestinal neoplasms
,
neuroendocrine tumors
,
type 2 diabetes mellitus
,
diabetes mellitus
,
hypertension
,
glucose metabolism disorders
,
metabolic diseases
,
endocrine system diseases
,
breast neoplasms
Mk3475
uveal neoplasms
,
uveal melanoma
,
neoplasms
,
melanoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use